Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,720 | -21,400 | -20,380 | -15,450 | -11,900 |
| Depreciation Amortization | 220 | 230 | 210 | 180 | 140 |
| Other Working Capital | -660 | -2,630 | 1,290 | 100 | 960 |
| Other Operating Activity | -3,500 | 410 | 1,700 | 1,870 | 310 |
| Operating Cash Flow | $-28,660 | $-23,390 | $-17,180 | $-13,300 | $-10,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | -110 | -90 | -190 | -110 |
| Other Investing Activity | 3,030 | 4,610 | 10,110 | -3,570 | -12,020 |
| Investing Cash Flow | $2,930 | $4,500 | $10,020 | $-3,760 | $-12,130 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 21,390 | 28,640 | 0 | 410 | 38,990 |
| Financing Cash Flow | $21,390 | $28,640 | $0 | $410 | $38,990 |
| Beginning Cash Position | 18,270 | 8,520 | 15,680 | 32,340 | 15,980 |
| End Cash Position | 13,930 | 18,270 | 8,520 | 15,680 | 32,340 |
| Net Cash Flow | $-4,340 | $9,740 | $-7,160 | $-16,650 | $16,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,660 | -23,390 | -17,180 | -13,300 | -10,490 |
| Free Cash Flow | -28,660 | -23,390 | -17,180 | -13,300 | -10,490 |